Abrégé

The invention relates to producing agents which are used for forming coatings which exhibit the properties intrinsic to polytetrafluoroethylen, i.e., resistance to chemical aggressive media, antifriction and water-repellent properties, in particular to fluor-contaning telomers and to methods for producing coatings based thereon. The inventive method for producing alkylketone fluorotelomers involves carrying out a free-radical telomerisation reaction of unsaturated perfluorolefins (for example tetrafluoroethylene TFE) in a telogen liquid medium with the ratio of TFE/telogen 0.5-20/100. In the preferred variant, the reaction is carried out with the ratio of TFE/telogen (0.7-3)/100 in such a way that a telomer colloidal solution is formed, which solution is used for applying heat-resistant highly-adhesive coatings the thickness of which ranges from 1 to 5 mkm.

Classes IPC  ?

• C08F 114/26 - Tétrafluoro-éthylène
• C08F 2/38 - Polymérisation utilisant des régulateurs, p. ex. des agents d'arrêt de chaîne
• C08F 2/54 - Polymérisation amorcée par énergie ondulatoire ou par rayonnement corpusculaire par des rayons X ou des électrons
• C09D 127/18 - Homopolymères ou copolymères du tétrafluoro-éthylène

Abrégé

The invention relates to electroluminescent material containing an organic luminescent substance. The novel electroluminescent material consists of an electron injecting layer, an active luminescent layer based on a metal chelate complex, a hole transport layer and a hole injecting layer. The electroluminescent material contains zinc complexes based on sulfonylamine derivatives of 2-phenyl-benzoxasole or 2-phenyl-benzothiasole as a luminescent substance. The material preferably contains a mixture of triphenylamine oligomers as a hole transport layer. Said invention makes it possible to develop an electroluminescent material, the emission colour of which is close to white and which exhibits a high luminous efficiency and a high heat stability.

Classes IPC  ?

• C09K 11/06 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances organiques luminescentes
• C07D 263/57 - Radicaux aryle ou aryle substitués
• C07D 277/66 - Benzothiazoles avec uniquement des radicaux hydrocarbonés ou des radicaux hydrocarbonés substitués liés en position 2 avec des cycles ou des systèmes cycliques aromatiques liés directement en position 2
• C07F 3/06 - Composés du zinc
• H05B 33/14 - Sources lumineuses avec des éléments radiants ayant essentiellement deux dimensions caractérisées par la composition chimique ou physique ou la disposition du matériau électroluminescent

Abrégé

The invention relates to electroluminescent materials containing organic luminescent substance. The inventive novel electroluminescent material comprises an electron injecting layer, an active luminescent layer based on a luminescent substance, a hole-transport layer and a hole-injecting layer. The material contains metallocomplexes of quinoline-sulfanylamine derivatives in the form of a luminescent substance. The inventive electroluminescent material exhibits the increased time resource, resulting from the high resistance of the active luminescent layer to crystallisation and hydrolysis, and the high heat resistance of the hole-transport layer.

Classes IPC  ?

• C09K 11/06 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances organiques luminescentes
• C07F 3/00 - Composés contenant des éléments des groupes 2 ou 12 du tableau périodique
• C07D 215/58 - Composés hétérocycliques contenant les systèmes cycliques de la quinoléine ou de la quinoléine hydrogénée avec des hétéro-atomes liés directement à l'atome d'azote du cycle
• C07D 215/40 - Atomes d'azote liés en position 8

Abrégé

The invention relates to a method for processing condensed fuels, including solid fuel wastes, by pyrolysis and by gasifying the organic constituent thereof. The inventive method can be used for efficiently processing fuels, including fine-dispersed and easily sintering fuels. The inventive method consists in loading a condensed fuel in a reactor to which a gasifying oxygen-containing agent is supplied in a countercurrent manner, in organising a fuel pyrolysis in the reactor and, subsequently, in burning/gasifying pyrolysis carbon residues in the fuel dense layer. The reactor is embodied in the form of a rotary tilting furnace whose tilt angle to the horizon is equal to 22-65° and which is rotatable for stabilising a burning process. Combustible gases produced during pyrolysis and gasification can be used in the form of a fuel.

Classes IPC  ?

• C10J 3/00 - Production de gaz contenant de l'oxyde de carbone et de l'hydrogène, p. ex. du gaz de synthèse ou du gaz de ville, à partir de matières carbonées solides par des procédés d'oxydation partielle faisant intervenir de l'oxygène ou de la vapeur
• F23G 5/027 - Procédés ou appareils, p. ex. incinérateurs, spécialement adaptés à la combustion de déchets ou de combustibles pauvres comportant un traitement préalable par pyrolyse ou par gazéification
• F23G 5/20 - Procédés ou appareils, p. ex. incinérateurs, spécialement adaptés à la combustion de déchets ou de combustibles pauvres avec combustion dans des tambours rotatifs ou oscillants
• F27B 7/00 - Fours à tambours rotatifs, c.-à-d. horizontaux ou légèrement inclinés

Abrégé

The invention relates to basic organic synthesis, in particular to a two-stage process for producing methyl-ethyl ketone (MEK). Said method comprises of two stages consisting in producing n-butenes by catalytically dimerising ethylene and in catalytically oxidising said n-butenes by nitrogen oxide (I) The ethylene dimerisation is carried under a catalytical system action comprising titanium alkoxide of general formula Ti(OR)n and an aluminium organic compound of general formula AlR3 in a simple ether or tetrahydrofuran medium at concentrations of Ti(OR)n = (0.2 ÷2.0)×10-3 M. molar ratios Al/Ti=6-150, T=20-150 °C, P ethylene 0.1-4.0 MPa in eballated or tubular-and-slotted reactors in the absence or presence of hydrogen. The n-butene catalytical oxidising in MEK is carried out by nitrogen oxide (I) in a liquid phase with a temperature ranging from 20 to 150 °C at a total pressure of a gas mixture of 0.1-0.35 MPa in the presence of catalysts based on peroxopolyoxo metallate complexes-tetrakis-(oxo diperoxo metallate)- phosphate(3-) in combination with ammonium quaternary cations of general formula (II), wherein Me-Mo, W,V; Q3 is an ammonium quaternary cation containing alkyl chains C4-C8 or N-hexadecylpyridinium.

Classes IPC  ?

• C07C 49/10 - Méthyléthylcétone
• C07C 11/08 - Alcènes à quatre atomes de carbone
• C07C 2/08 - Procédés catalytiques
• B01J 27/18 - PhosphoreSes composés contenant de l'oxygène avec des métaux
• B01J 27/19 - Molybdène
• B01J 27/199 - Vanadium avec du chrome, du molybdène, du tungstène ou du polonium

Abrégé

The invention relates to dicarbonic acid derivatives, in particular to monooximides and dicarbonic acid dioxydiamides which are physiologically active substances and can be used in the form of low-toxic and non-toxic agents for enhancing anti-tumor and anti-metastasis effects of known cytostatics (cyclophosphane and cisplatin) in cytostatic chemotherapy of tumors. The aim of said invention is to extend the variety of agents acting on a live organism for enhancing anti-tumor and anti-metastasis effects of known cytostatics. Said aim is attained by the properties of monooximides and dicarbonic acid dioxydiamides. The invention is characterised by the use of dicarbonic acid derivatives in the form of agents for enhancing anti-tumor and anti-metastasis effects of cytostatics of formulas given in a description. The inventive compounds can be used in medicine in the form of low-toxic means for enhancing anti-tumor and anti-metastasis effects of known cytostatics and for reducing the cytostatic therapeutic dose by four times. The use of the inventive compounds in combination with cisplatin minimum doses makes it possible to totally inhibit the metastasis process of experimental melanoma B-16. In addition, the use of minimum doses of the inventive compounds in combination with the cytostatic minimum doses (when said preparations are individually inefficient ) makes it possible to attain a high therapeutic effect for treating (the survival of test group of animals having leukaemia P-338 is equal to 100%)

Classes IPC  ?

• C07C 259/06 - Composés contenant des groupes carboxyle, un atome d'oxygène d'un groupe carboxyle étant remplacé par un atome d'azote, cet atome d'azote étant lié de plus à un atome d'oxygène et ne faisant pas partie de groupes nitro ou nitroso sans remplacement de l'autre atome d'oxygène du groupe carboxyle, p. ex. acides hydroxamiques ayant des atomes de carbone de groupes hydroxamique liés à des atomes d'hydrogène ou à des atomes de carbone acycliques
• A61K 31/16 - Amides, p. ex. acides hydroxamiques
• A61P 35/04 - Agents anticancéreux spécifiques pour le traitement des métastases